The cleavage site contributes to the unique localization and function of HER4 and likely plays a critical role in regulating HER2 positive carcinomas and the therapeutic response to HER2 over-expressing tumors[11, 18, 19, 24-28]. The gene discussed is ERBB2; the disease is carcinoma.